Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Marine sponge-derived and synthetic antitumor compounds patented by Pharma Mar

Oct. 9, 2001

AMDL acquires combination immunogene therapy technology

Oct. 9, 2001

Genmab and Immunex to codevelop antibody therapeutics for lymphoma

Oct. 9, 2001

Pangene's DNA repair protein inhibitors reverse resistance in human cancers

Oct. 9, 2001

Recombinant molecule selected for clinical development as mucositis therapy by Alizyme

Oct. 8, 2001

Enrollment in phase II LDP-341 multiple myeloma trial completed ahead of schedule

Oct. 8, 2001

NeoPharm initiates phase I/II clinical trial for LEM in cancer

Oct. 8, 2001

Folate-based thymidylate synthase inhibitor CW-252053 safe and effective in tumor-bearing mice

Oct. 8, 2001

Additional patient enrollment suspended in phase III study of Aptosyn and Taxotere

Oct. 8, 2001

Apoptotic effect of TAS-106 investigated in human leukemia cells

Oct. 5, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...